NCT02801409

Brief Summary

Available studies suggest that regional anesthesia-analgesia may decrease the occurrence of recurrence/metastasis in patients after cancer surgery. However, evidences from prospective studies are still lacking. The purpose of this randomized controlled trial is to investigate the effect of epidural anesthesia-analgesia on recurrence-free survival in patients undergoing lung cancer surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable lung-cancer

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 25, 2015

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 12, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 15, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2017

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
Last Updated

August 27, 2020

Status Verified

August 1, 2020

Enrollment Period

2.5 years

First QC Date

June 12, 2016

Last Update Submit

August 25, 2020

Conditions

Keywords

Lung CancerSurgical ResectionEpidural Anesthesia and AnalgesiaCancer recurrence/metastasisLong-Term Outcome

Outcome Measures

Primary Outcomes (1)

  • Recurrence-free survival after surgery.

    Time from surgery to the earliest date of recurrence/metastasis or death from any cause, whichever came first.

    Up to 4 years after surgery.

Secondary Outcomes (8)

  • Rate of intensive care unit admission after surgery.

    Up to 30 days after surgery.

  • Incidence of postoperative complications during hospital stay.

    Up to 30 days after surgery.

  • Duration of chest tube placement.

    Up to 30 days after surgery.

  • Length of stay in hospital after surgery.

    Up to 30 days after surgery.

  • Rate of all-cause mortality during hospital stay after surgery.

    Up to 30 days after surgery.

  • +3 more secondary outcomes

Other Outcomes (7)

  • Pain intensity after surgery.

    During the first 3 days after surgery.

  • Recurrence-free survival in cancer patients.

    Up to 4 years after surgery.

  • Overall survival in cancer patients.

    Up to 4 years after surgery.

  • +4 more other outcomes

Study Arms (2)

General anesthesia alone

ACTIVE COMPARATOR

General anesthesia is performed during surgery; patient-controlled intravenous analgesia is provided after surgery.

Drug: General anesthesia alone

Combined epidural-general anesthesia

EXPERIMENTAL

Combined epidural-general anesthesia is performed during surgery; patient-controlled epidural analgesia is provided after surgery.

Drug: Combined epidural-general anesthesia

Interventions

General anesthesia is performed during surgery; patient-controlled intravenous analgesia is provided after surgery.

General anesthesia alone

Combined epidural-general anesthesia is performed during surgery; patient-controlled epidural analgesia is provided after surgery.

Combined epidural-general anesthesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (aged 18-80 years);
  • Clinically diagnosed as primary non-small cell lung cancer of stage IA to IIIA, and scheduled for radical surgery;
  • Agreed to receive patient-controlled analgesia after surgery.

You may not qualify if:

  • Distant metastasis, malignant tumor in other organs, or chemo-/radiotherapy or other anti-cancer therapy before surgery;
  • Comorbid with autoimmune diseases, or glucocorticoid/immunosuppressant therapy within 1 year;
  • History of schizophrenia, epilepsy or Parkinson disease, or unable to complete preoperative assessment due to severe dementia, language barrier, or end-stage disease;
  • Severe hepatic disease (Child-Pugh classification C), renal failure (serum creatinine \>442 umol/L or receiving renal replacement therapy), or American Society of Anesthesiologists classification IV or higher;
  • History of anesthesia and/or surgery within 1 year;
  • Contraindications to epidural anesthesia, including spinal deformity, coagulation dysfunction, local infection, and history of spinal trauma/surgery;
  • Allergic to any medications used during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University First Hospital

Beijing, Beijing Municipality, 100034, China

Location

Related Publications (42)

  • Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, D'Amico TA, Boyd JA. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 2009 Nov 15;115(22):5218-27. doi: 10.1002/cncr.24625.

    PMID: 19672942BACKGROUND
  • Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Lange CM, Li H. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. Ann Thorac Surg. 1999 Oct;68(4):1171-6. doi: 10.1016/s0003-4975(99)00678-5.

    PMID: 10543475BACKGROUND
  • Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth. 2010 Aug;105(2):106-15. doi: 10.1093/bja/aeq164.

    PMID: 20627881BACKGROUND
  • Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 2007 Dec 6;450(7171):903-7. doi: 10.1038/nature06309. Epub 2007 Nov 18.

    PMID: 18026089BACKGROUND
  • Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003 Oct;10(8):972-92. doi: 10.1245/aso.2003.02.007.

    PMID: 14527919BACKGROUND
  • Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg. 2000 Jul;232(1):58-65. doi: 10.1097/00000658-200007000-00009.

    PMID: 10862196BACKGROUND
  • Hofer SO, Molema G, Hermens RA, Wanebo HJ, Reichner JS, Hoekstra HJ. The effect of surgical wounding on tumour development. Eur J Surg Oncol. 1999 Jun;25(3):231-43. doi: 10.1053/ejso.1998.0634.

    PMID: 10336800BACKGROUND
  • Lennard TW, Shenton BK, Borzotta A, Donnelly PK, White M, Gerrie LM, Proud G, Taylor RM. The influence of surgical operations on components of the human immune system. Br J Surg. 1985 Oct;72(10):771-6. doi: 10.1002/bjs.1800721002.

    PMID: 2412626BACKGROUND
  • Carter JJ, Whelan RL. The immunologic consequences of laparoscopy in oncology. Surg Oncol Clin N Am. 2001 Jul;10(3):655-77.

    PMID: 11685934BACKGROUND
  • Tashiro T, Yamamori H, Takagi K, Hayashi N, Furukawa K, Nitta H, Toyoda Y, Sano W, Itabashi T, Nishiya K, Hirano J, Nakajima N. Changes in immune function following surgery for esophageal carcinoma. Nutrition. 1999 Oct;15(10):760-6. doi: 10.1016/s0899-9007(99)00151-3.

    PMID: 10501289BACKGROUND
  • Downing JE, Miyan JA. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today. 2000 Jun;21(6):281-9. doi: 10.1016/s0167-5699(00)01635-2.

    PMID: 10825740BACKGROUND
  • Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev. 2000 Dec;52(4):595-638.

    PMID: 11121511BACKGROUND
  • Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001 Feb 1;90(1-2):191-9. doi: 10.1016/s0304-3959(00)00403-6.

    PMID: 11166986BACKGROUND
  • Afsharimani B, Cabot PJ, Parat MO. Morphine use in cancer surgery. Front Pharmacol. 2011 Aug 8;2:46. doi: 10.3389/fphar.2011.00046. eCollection 2011.

    PMID: 21852973BACKGROUND
  • Xu YX, Ayala A, Chaudry IH. Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma. 1998 Feb;44(2):335-41. doi: 10.1097/00005373-199802000-00018.

    PMID: 9498507BACKGROUND
  • Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology. 1999 Sep;91(3):861-5. doi: 10.1097/00000542-199909000-00040. No abstract available.

    PMID: 10485799BACKGROUND
  • Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010 Jun 1;110(6):1636-43. doi: 10.1213/ANE.0b013e3181de0ab6. Epub 2010 Apr 30.

    PMID: 20435944BACKGROUND
  • Ishihara Y, Matsunaga K, Iijima H, Fujii T, Oguchi Y, Kagawa J. Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice. Psychoneuroendocrinology. 1999 Oct;24(7):713-26. doi: 10.1016/s0306-4530(99)00023-2.

    PMID: 10451907BACKGROUND
  • Freire-Garabal M, Nunez MJ, Balboa JL, Fernandez-Rial JC, Vallejo LG, Gonzalez-Bahillo J, Rey-Mendez M. Effects of alprazolam on cellular immune response to surgical stress in mice. Cancer Lett. 1993 Sep 30;73(2-3):155-60. doi: 10.1016/0304-3835(93)90258-b.

    PMID: 8221628BACKGROUND
  • Andersen BL, Farrar WB, Golden-Kreutz D, Kutz LA, MacCallum R, Courtney ME, Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst. 1998 Jan 7;90(1):30-6. doi: 10.1093/jnci/90.1.30.

    PMID: 9428780BACKGROUND
  • Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? Br J Anaesth. 2012 Dec;109 Suppl 1:i17-i28. doi: 10.1093/bja/aes421.

    PMID: 23242747BACKGROUND
  • Conrick-Martin I, Buggy DJ. The effects of anesthetic and analgesic techniques on immune function. J Clin Anesth. 2013 Jun;25(4):253-4. doi: 10.1016/j.jclinane.2013.04.003. Epub 2013 Apr 26. No abstract available.

    PMID: 23624071BACKGROUND
  • Ahlers O, Nachtigall I, Lenze J, Goldmann A, Schulte E, Hohne C, Fritz G, Keh D. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. Br J Anaesth. 2008 Dec;101(6):781-7. doi: 10.1093/bja/aen287. Epub 2008 Oct 15.

    PMID: 18922851BACKGROUND
  • Piegeler T, Votta-Velis EG, Liu G, Place AT, Schwartz DE, Beck-Schimmer B, Minshall RD, Borgeat A. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012 Sep;117(3):548-59. doi: 10.1097/ALN.0b013e3182661977.

    PMID: 22846676BACKGROUND
  • Waurick R, Van Aken H. Update in thoracic epidural anaesthesia. Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):201-13. doi: 10.1016/j.bpa.2004.12.001.

    PMID: 15966493BACKGROUND
  • Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008 Aug;109(2):180-7. doi: 10.1097/ALN.0b013e31817f5b73.

    PMID: 18648226BACKGROUND
  • Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006 Oct;105(4):660-4. doi: 10.1097/00000542-200610000-00008.

    PMID: 17006061BACKGROUND
  • Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S, Pillay J, Finucane BT. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth. 2010 Feb;57(2):107-12. doi: 10.1007/s12630-009-9214-7.

    PMID: 19911247BACKGROUND
  • Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth. 2011 Jun;106(6):814-22. doi: 10.1093/bja/aer055. Epub 2011 Mar 24.

    PMID: 21436156BACKGROUND
  • Cummings KC 3rd, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology. 2012 Apr;116(4):797-806. doi: 10.1097/ALN.0b013e31824674f6.

    PMID: 22273991BACKGROUND
  • Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth. 2010 Aug;105(2):145-9. doi: 10.1093/bja/aeq156. Epub 2010 Jun 23.

    PMID: 20573631BACKGROUND
  • Lai R, Peng Z, Chen D, Wang X, Xing W, Zeng W, Chen M. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg. 2012 Feb;114(2):290-6. doi: 10.1213/ANE.0b013e318239c2e3. Epub 2011 Nov 21.

    PMID: 22104077BACKGROUND
  • Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth. 2011 Aug;107(2):164-70. doi: 10.1093/bja/aer100. Epub 2011 May 17.

    PMID: 21586443BACKGROUND
  • Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg. 2008 Jul;107(1):325-32. doi: 10.1213/ane.0b013e3181770f55.

    PMID: 18635504BACKGROUND
  • Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010 Jul;113(1):27-34. doi: 10.1097/ALN.0b013e3181de6d0d.

    PMID: 20508494BACKGROUND
  • Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN, Studer UE, Stueber F, Burkhard FC. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology. 2010 Sep;113(3):570-6. doi: 10.1097/ALN.0b013e3181e4f6ec.

    PMID: 20683253BACKGROUND
  • Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI; ANZCA Trials Group Investigators. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ. 2011 Mar 29;342:d1491. doi: 10.1136/bmj.d1491.

    PMID: 21447587BACKGROUND
  • Taylor MD, Nagji AS, Bhamidipati CM, Theodosakis N, Kozower BD, Lau CL, Jones DR. Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2012 Jun;93(6):1813-20; discussion 1820-1. doi: 10.1016/j.athoracsur.2012.03.031. Epub 2012 Apr 26.

    PMID: 22542070BACKGROUND
  • Alberts WM. Follow up and surveillance of the patient with lung cancer: what do you do after surgery? Respirology. 2007 Jan;12(1):16-21. doi: 10.1111/j.1440-1843.2006.00956.x.

    PMID: 17207020BACKGROUND
  • Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):e437S-e454S. doi: 10.1378/chest.12-2365.

    PMID: 23649451BACKGROUND
  • Bruzzi JF, Munden RF. PET/CT imaging of lung cancer. J Thorac Imaging. 2006 May;21(2):123-36. doi: 10.1097/00005382-200605000-00004.

    PMID: 16770229BACKGROUND
  • Pei L, Tan G, Wang L, Guo W, Xiao B, Gao X, Wang L, Li H, Xu Z, Zhang X, Zhao J, Yi J, Huang Y. Comparison of combined general-epidural anesthesia with general anesthesia effects on survival and cancer recurrence: a meta-analysis of retrospective and prospective studies. PLoS One. 2014 Dec 30;9(12):e114667. doi: 10.1371/journal.pone.0114667. eCollection 2014.

    PMID: 25548913BACKGROUND

MeSH Terms

Conditions

Lung NeoplasmsNeoplasm Recurrence, LocalNeoplasm MetastasisAgnosia

Interventions

Anesthesia, General

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Dong-Xin Wang, MD, PhD

    Peking University First Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 12, 2016

First Posted

June 15, 2016

Study Start

May 25, 2015

Primary Completion

November 11, 2017

Study Completion

November 30, 2019

Last Updated

August 27, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations